C.DIAG® – Dry eye diagnostic aid platform

C.DIAG® – Dry eye diagnostic aid platform

C.DIAG® – Dry eye diagnostic aid platform

Lumibird Medical announces the launch of the C.DIAG®, a new-generation dry eye diagnostic aid platform with integrated AI algorithms. This new component of the C.SUITETM offer enables healthcare professionals to diagnose, treat and educate dry eye patients and positions Lumibird Medical as a major player in this growing market.

Dry Eye Disease (DED) is a public health problem that affected 1.4 billion people in 2021* and represents today the second cause of ophthalmologic consultations after visual acuity*. The management of DED has increasingly become a challenge in many specialties such as glaucoma, refractive & cataract surgeries and contact lenses.

The manufacturer Quantel Medical, Lumibird Medical group, is launching C.DIAG®, an automatic Dry Eye diagnostic aid platform.

"C.DIAG is an automated diagnostic aid platform, the most complete on the market, integrating multiple exams as transillumination meibography and an autofocus HD camera for unrivalled image quality and automatic, accurate and reproducible results. The incorporated Artificial Intelligence is based on algorithms derived from more than one million clinically validated images."

The C.DIAG® is the third feature of the unique C.SUITETM offer which includes the equipment to diagnose- C.DIAG®, treat – C.STIM® and educate the patient about DED.
“The DED symptoms are often misunderstood. This multifactorial pathology is often underdiagnosed and underestimated. We are convinced that this new innovative C.SUITETM offer is a premium diagnosis and treatment solution to healthcare professionals confronted with the daily challenge of dry eye management.”

Jean-Marc Gendre, CEO of Lumibird Medical

Delegates attending the SFO Congress in Paris from May 04th to May 06th will have the opportunity to discover the C.SUITETM on the Lumibird Medical stand.

For more information about C.DIAG®, visit our website for healthcare professionnals: 

* : Market Scope© Market Study: 2021 Dry Eye Products Market Report, global analysis for 2020 to 2026

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@lumibirdmedical.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.